Allergen specific sublingual immunotherapy in children with asthma and allergic rhinitis
- 135 Downloads
The incidence of asthma and allergic rhinitis (AR) is significantly increased, especially in younger children. Current treatment for children with asthma and allergic rhinitis include allergen avoidance, standard pharmacotherapy, and immunotherapy. Since standard pharmacotherapy is prescribed for symptoms, immunotherapy at present plays an important role in the treatment of allergic diseases. This article presents insights into the up-to-date understanding of immunotherapy in the treatment of children with allergic rhinitis and asthma.
PubMed articles published from 1990 to 2014 were reviewed using the MeSH terms "asthma", "allergic rhinitis", "children", and "immune therapy". Additional articles were identified by hand searching of the references in the initial search.
Numerous studies have shown that sublingual application of allergen specific immunotherapy (SLIT) is an adequate, safe and efficient substitution to subcutaneous route of allergens administration (SCIT) in the treatment of IgE-mediated respiratory tract allergies in children. According to the literature, better clinical efficacy is connected with the duration of treatment and mono sensitized patients.
At least 3 years of treatment and stable asthma before the immunotherapy are positive predictors of good clinical efficacy and tolerability of SLIT. SLIT reduces the symptoms of allergic diseases and the use of medicaments, and improves the quality of life of children with the diseases.
Key wordsallergic asthma allergic rhinitis allergic sensitization immunotherapy
Unable to display preview. Download preview PDF.
- 2.Black JH. The oral administration of pollen: clinical report. J Lab Clin Med 1928;13:709–713.Google Scholar
- 12.Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, et al. Immune responses in healthy and allergic Individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567–1575.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Laaksonen K, Junikka M, Lahesmaa R, Terho EO, Savolainen J. In vitro allergen-induced mRNA expression of signaling lymphocytic activation molecule by PBMC of patients with allergic rhinitis is increased during specific pollen immunotherapy. J Allergy Clin Immunol 2003;112:1171–1177.CrossRefPubMedGoogle Scholar
- 17.Faith A, Richards DF, Verhoef A, Lamb JR, Lee TH, Hawrylowicz CM. Impaired secretion of interleukin-4 and interleukin-13 by allergen-specific T cells correlates with defective nuclear expression of NF-AT2 and jun B: relevance to immunotherapy. Clin Exp Allergy 2003;33:1209–1215.CrossRefPubMedGoogle Scholar
- 32.Tari G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A doubleblind study. Allergol Immunopathol (Madr) 1990;18:277–284.Google Scholar
- 34.Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André C, et al. Double blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998;53:662–672.CrossRefPubMedGoogle Scholar
- 35.La Rosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425–432.CrossRefPubMedGoogle Scholar
- 44.Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Assessment of sublingual immunotherapy efficacy in children with house dust miteinduced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007;18:47–57.CrossRefPubMedGoogle Scholar
- 51.Hedlin G, van HM. The role of immuntherapy in the managment of childhood asthma. Ther Adv Respir Dis 2012;127:30–38.Google Scholar
- 57.Yoselin A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB. et al. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol 2012;157:288–298.Google Scholar
- 74.Medical Dictionary for Regulatory Activities (MedDRA). Maintenance support services and organization. http://www.meddra.com (Accessed October 1, 2014).Google Scholar